We are live on
!
Find out more
AS
Altshuler Shaham Portfolio holdings
AUM
$8.04B
1-Year Est. Return
44.04%
This Fund
S&P 500
This Quarter
Est. Return
+3.48%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
–
AUM
$9.9B
AUM Growth
+$4.89B
(+98%)
Cap. Flow
+$4.7B
Cap. Flow
% of AUM
47.52%
Top 10 Holdings %
Top 10 Hldgs %
63.07%
Holding
564
New
173
Increased
130
Reduced
128
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$776M |
| 3 |
TSMC
TSM
|
+$639M |
| 4 |
Global X Cybersecurity ETF
BUG
|
+$569M |
| 5 |
Amazon
AMZN
|
+$522M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$508M |
| 2 |
Synchrony
SYF
|
+$154M |
| 3 |
Simon Property Group
SPG
|
+$26.3M |
| 4 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
+$21.2M |
| 5 |
iShares MSCI South Korea ETF
EWY
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.7% |
| 2 | Consumer Discretionary | 12.63% |
| 3 | Communication Services | 12.24% |
| 4 | Consumer Staples | 6.18% |
| 5 | Financials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CRISPR Therapeutics
CRSP
$5.22B
| $122K | ﹤0.01% |
+1,000
| New | +$151K |
|
202
10x Genomics
TXG
$7.58B
| $122K | ﹤0.01% |
673
+77
| +13% | +$13.3K |
|
203
ResMed
RMD
$32.9B
| $121K | ﹤0.01% |
625
-174
| -22% | -$34.9K |
|
204
DexCom
DXCM
$34.5B
| $120K | ﹤0.01% |
1,336
| – | – |
|
205
Teladoc Health
TDOC
$1.26B
| $118K | ﹤0.01% |
650
+150
| +30% | +$34.8K |
|
206
Mettler-Toledo International
MTD
$28.7B
| $116K | ﹤0.01% |
100
-399
| -80% | -$462K |
|
207
MannKind Corp
MNKD
$1.2B
| $115K | ﹤0.01% |
29,313
+16,039
| +121% | +$65.8K |
|
208
STAAR Surgical
STAA
$1.26B
| $115K | ﹤0.01% |
1,094
-45
| -4% | -$4.51K |
|
209
Texas Instruments
TXN
$250B
| $115K | ﹤0.01% |
608
+248
| +69% | +$43.1K |
|
|
CUTR
210
DELISTED
Cutera, Inc.
CUTR
| $114K | ﹤0.01% |
3,808
+2,213
| +139% | +$65.4K |
|
211
Tactile Systems Technology
TCMD
$537M
| $113K | ﹤0.01% |
+2,076
| New | +$111K |
|
212
AbbVie
ABBV
$443B
| $110K | ﹤0.01% |
1,016
-615
| -38% | -$65.8K |
|
213
Keysight
KEYS
$60.5B
| $106K | ﹤0.01% |
+737
| New | +$105K |
|
214
Omnicell
OMCL
$1.72B
| $105K | ﹤0.01% |
812
+474
| +140% | +$60.8K |
|
|
SAGE
215
DELISTED
Sage Therapeutics
SAGE
| $105K | ﹤0.01% |
+1,403
| New | +$115K |
|
|
RDS.A
216
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $104K | ﹤0.01% |
2,650
| – | – |
|
217
LeMaitre Vascular
LMAT
$1.87B
| $103K | ﹤0.01% |
2,116
+1,123
| +113% | +$52.6K |
|
218
United Therapeutics
UTHR
$21.5B
| $103K | ﹤0.01% |
618
+338
| +121% | +$56.4K |
|
219
CareDx
CDNA
$2.45B
| $102K | ﹤0.01% |
1,493
+181
| +14% | +$14.1K |
|
|
ATRS
220
DELISTED
Antares Pharma, Inc.
ATRS
| $100K | ﹤0.01% |
+24,404
| New | +$106K |
|
221
Costco
COST
$427B
| $99K | ﹤0.01% |
282
-29
| -9% | -$10.1K |
|
222
Alphatec Holdings
ATEC
$1.51B
| $98K | ﹤0.01% |
6,223
+3,164
| +103% | +$49.8K |
|
223
NovoCure
NVCR
$2.02B
| $98K | ﹤0.01% |
743
-2,949
| -80% | -$466K |
|
224
Inspire Medical Systems
INSP
$1.68B
| $95K | ﹤0.01% |
460
+17
| +4% | +$3.61K |
|
225
Phreesia
PHR
$780M
| $91K | ﹤0.01% |
1,739
+997
| +134% | +$62.8K |
|
Similar funds
VIM
FIA
EGM
CCM
WA
PC
PGFC
IMCOOI
Altshuler Shaham's Q1 2021 Portfolio in Review
As of Q1 2021, Altshuler Shaham held 564 positions worth $9.9B, up 98% from $5.01B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Altshuler Shaham deployed $4.7B of net new capital in Q1 2021, opening 173 new positions and adding to 130 existing holdings. Its largest new stake was Global X Cybersecurity ETF: 20,793,169 shares worth $521M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $508M trimmed.
- Altshuler Shaham's largest Q1 2021 buy was Global X Cybersecurity ETF: 20,793,169 shares worth $521M.
- Altshuler Shaham added most to Microsoft in Q1 2021, an estimated $1.02B increase.
- Altshuler Shaham's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $508M.
- Altshuler Shaham fully exited First Trust NASDAQ Cybersecurity ETF in Q1 2021, selling an estimated $21.2M.
- Altshuler Shaham's ten largest holdings make up 63% of its $9.9B portfolio in Q1 2021.
- Altshuler Shaham opened 173 new positions and closed 115 in Q1 2021.
- Altshuler Shaham's portfolio value rose 98% quarter-over-quarter to $9.9B.
Based on Altshuler Shaham's 13F filing for Q1 2021, filed 13 May 2021.